Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules

Bioorganic & Medicinal Chemistry Letters
2000.0

Abstract

An in vitro assay based on the expression of Fluci reporter gene under the translational control of HCV IRES was used to evaluate and screen compound libraries. A structure-activity relationship study on a phenazine hit was conducted. Our data suggest that an intact phenazine or phenazine-like core with two distal polar substitutions is crucial for potency.

Knowledge Graph

Similar Paper

Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules
Bioorganic & Medicinal Chemistry Letters 2000.0
2-Aminobenzoxazole ligands of the hepatitis C virus internal ribosome entry site
Bioorganic & Medicinal Chemistry Letters 2014.0
Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core
ACS Medicinal Chemistry Letters 2014.0
Design, facile synthesis and biological evaluations of novel pyrano[3,2- a ]phenazine hybrid molecules as antitumor agents
European Journal of Medicinal Chemistry 2017.0
In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase
European Journal of Medicinal Chemistry 2017.0
Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs
Bioorganic & Medicinal Chemistry Letters 2014.0
Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors
European Journal of Medicinal Chemistry 2013.0
Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection
Journal of Medicinal Chemistry 2016.0
Anti-HCV Bioactivity of Pseudoguaianolides from <i>Parthenium hispitum</i>
Journal of Natural Products 2007.0
New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling
European Journal of Medicinal Chemistry 2019.0